| Item Type | Name |
|
Academic Article
|
Effect of cardiovascular comorbidities and concomitant aspirin use on selection of cyclooxygenase inhibitor among rheumatologists.
|
|
Academic Article
|
Simplified composite disease activity measures in rheumatoid arthritis: should they be used in standard care?
|
|
Academic Article
|
Functional improvement after patients with rheumatoid arthritis start a new disease modifying antirheumatic drug (DMARD) associated with frequent changes in DMARD: the CORRONA database.
|
|
Academic Article
|
Evaluation of composite measures of treatment response without acute-phase reactants in patients with rheumatoid arthritis.
|
|
Academic Article
|
Physician preference motivates the use of anti-tumor necrosis factor therapy independent of clinical disease activity.
|
|
Academic Article
|
A modified rheumatoid arthritis disease activity score without acute-phase reactants (mDAS28) for epidemiological research.
|
|
Academic Article
|
Comparative analysis of disease activity measures, use of biologic agents, body mass index, radiographic features, and bone density in psoriatic arthritis and rheumatoid arthritis patients followed in a large U.S. disease registry.
|
|
Academic Article
|
Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis.
|
|
Academic Article
|
High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis.
|
|
Academic Article
|
Greater likelihood of remission in rheumatoid arthritis patients treated earlier in the disease course: results from the Consortium of Rheumatology Researchers of North America registry.
|
|
Academic Article
|
Prescribing practices in a US cohort of rheumatoid arthritis patients before and after publication of the American College of Rheumatology treatment recommendations.
|
|
Academic Article
|
A comparative effectiveness study of adalimumab, etanercept and infliximab in biologically naive and switched rheumatoid arthritis patients: results from the US CORRONA registry.
|
|
Academic Article
|
Malignancy validation in a United States registry of rheumatoid arthritis patients.
|
|
Academic Article
|
The temporal relationship between depression and rheumatoid arthritis disease activity, treatment persistence and response: a systematic review.
|
|
Academic Article
|
The role of the FcGRIIIa polymorphism in modifying the association between treatment and outcome in patients with rheumatoid arthritis treated with rituximab versus TNF-a antagonist therapies.
|
|
Academic Article
|
Comparative effectiveness of nonbiologic versus biologic disease-modifying antirheumatic drugs for rheumatoid arthritis.
|
|
Academic Article
|
Assessment of coxib utilization by rheumatologists for nonsteroidal antiinflammatory drug gastroprotection prior to the coxib market withdrawals.
|
|
Academic Article
|
Tumor necrosis factor antagonist responsiveness in a United States rheumatoid arthritis cohort.
|
|
Academic Article
|
Factors influencing fracture risk, T score, and management of osteoporosis in patients with rheumatoid arthritis in the Consortium of Rheumatology Researchers of North America (CORRONA) registry.
|
|
Academic Article
|
Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity.
|
|
Academic Article
|
Risk of elevated liver enzymes associated with TNF inhibitor utilisation in patients with rheumatoid arthritis.
|
|
Academic Article
|
Thresholds in disease activity for switching biologics in rheumatoid arthritis patients: experience from a large U.S. cohort.
|
|
Academic Article
|
Treatment of rheumatoid arthritis with marine and botanical oils: influence on serum lipids.
|
|
Academic Article
|
Significance of sex in achieving sustained remission in the consortium of rheumatology researchers of North America cohort of rheumatoid arthritis patients.
|
|
Concept
|
Arthritis, Rheumatoid
|
|
Concept
|
Arthritis, Psoriatic
|
|
Academic Article
|
Patient perspectives on achieving treat-to-target goals: a critical examination of patient-reported outcomes.
|
|
Academic Article
|
Comparative cancer risk associated with methotrexate, other non-biologic and biologic disease-modifying anti-rheumatic drugs.
|
|
Academic Article
|
Higher rates and clustering of abnormal lipids, obesity, and diabetes mellitus in psoriatic arthritis compared with rheumatoid arthritis.
|
|
Academic Article
|
Racial and ethnic disparities in disease activity in patients with rheumatoid arthritis.
|
|
Academic Article
|
A comparison of the malignancy incidence among patients with psoriatic arthritis and patients with rheumatoid arthritis in a large US cohort.
|
|
Academic Article
|
"Design characteristics of the CORRONA CERTAIN study: a comparative effectiveness study of biologic agents for rheumatoid arthritis patients".
|
|
Academic Article
|
Treatment of rheumatoid arthritis with marine and botanical oils: an 18-month, randomized, and double-blind trial.
|
|
Academic Article
|
A description of patient- and rheumatologist-reported depression symptoms in an American rheumatoid arthritis registry population.
|
|
Academic Article
|
Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year.
|
|
Academic Article
|
The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor.
|
|
Academic Article
|
The rheumatoid arthritis treat-to-target trial: a cluster randomized trial within the Corrona rheumatology network.
|
|
Academic Article
|
Temporal associations between the different domains of rheumatoid arthritis disease activity and the onset of patient-reported depressive symptoms.
|
|
Academic Article
|
Discontinuation of tumour necrosis factor inhibitors in patients with rheumatoid arthritis in low-disease activity: persistent benefits. Data from the Corrona registry.
|
|
Academic Article
|
Temporal effect of depressive symptoms on the longitudinal evolution of rheumatoid arthritis disease activity.
|
|
Academic Article
|
Effectiveness of Rituximab for the Treatment of Rheumatoid Arthritis in Patients with Prior Exposure to Anti-TNF: Results from the CORRONA Registry.
|
|
Academic Article
|
Subcutaneous nodules are associated with cardiovascular events in patients with rheumatoid arthritis: results from a large US registry.
|
|
Academic Article
|
Comparative effectiveness and safety of rituximab versus subsequent anti-tumor necrosis factor therapy in patients with rheumatoid arthritis with prior exposure to anti-tumor necrosis factor therapies in the United States Corrona registry.
|
|
Academic Article
|
Using epidemiological registry data to provide background rates as context for adverse events in a rheumatoid arthritis drug development program: a coordinated approach.
|
|
Academic Article
|
Incidence and Predictors of Biological Antirheumatic Drug Discontinuation Attempts among Patients with Rheumatoid Arthritis in Remission: A CORRONA and NinJa Collaborative Cohort Study.
|
|
Academic Article
|
Herpes Zoster Reactivation in Patients With Rheumatoid Arthritis: Analysis of Disease Characteristics and Disease-Modifying Antirheumatic Drugs.
|
|
Academic Article
|
Methodological Challenges When Comparing Demographic and Clinical Characteristics of International Observational Registries.
|
|
Academic Article
|
Identifying factors associated with concordance with the American College of Rheumatology rheumatoid arthritis treatment recommendations.
|
|
Academic Article
|
A Prospective Evaluation of the Effects of Prevalent Depressive Symptoms on Disease Activity in Rheumatoid Arthritis Patients Treated With Biologic Response Modifiers.
|
|
Academic Article
|
Can rheumatoid arthritis (RA) registries provide contextual safety data for modern RA clinical trials? The case for mortality and cardiovascular disease.
|
|
Academic Article
|
How comparable are rates of malignancies in patients with rheumatoid arthritis across the world? A comparison of cancer rates, and means to optimise their comparability, in five RA registries.
|
|
Academic Article
|
Characteristics Associated with Biologic Monotherapy Use in Biologic-Naive Patients with Rheumatoid Arthritis in a US Registry Population.
|
|
Academic Article
|
Dosing of Intravenous Tocilizumab in a Real-World Setting of Rheumatoid Arthritis: Analyses from the Corrona Registry.
|
|
Academic Article
|
Risk of Infection Associated With Subsequent Biologic Agent Use After Rituximab: Results From a National Rheumatoid Arthritis Patient Registry.
|
|
Academic Article
|
Comparative effectiveness of abatacept versus tocilizumab in rheumatoid arthritis patients with prior TNFi exposure in the US Corrona registry.
|
|
Academic Article
|
Benefit of biologics initiation in moderate versus severe rheumatoid arthritis: evidence from a United States registry.
|
|
Academic Article
|
Prevalence of cardiovascular disease and major risk factors in patients with rheumatoid arthritis: a multinational cross-sectional study.
|
|
Academic Article
|
Impact of Tocilizumab Monotherapy on Clinical and Patient-Reported Quality-of-Life Outcomes in Patients with Rheumatoid Arthritis.
|
|
Academic Article
|
Infection rates in patients from five rheumatoid arthritis (RA) registries: contextualising an RA clinical trial programme.
|
|
Academic Article
|
Real-world Comparative Effectiveness of Tocilizumab Monotherapy vs. Tumor Necrosis Factor Inhibitors with Methotrexate in Patients with Rheumatoid Arthritis.
|
|
Academic Article
|
Clinical and demographic factors associated with change and maintenance of disease severity in a large registry of patients with rheumatoid arthritis.
|
|
Academic Article
|
Long-Term Effectiveness of Adalimumab in Patients with Rheumatoid Arthritis: An Observational Analysis from the Corrona Rheumatoid Arthritis Registry.
|
|
Academic Article
|
Cluster-Randomized Trial of a Behavioral Intervention to Incorporate a Treat-to-Target Approach to Care of US Patients With Rheumatoid Arthritis.
|
|
Academic Article
|
Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritis.
|
|
Academic Article
|
Outcomes of infliximab dose escalation in patients with rheumatoid arthritis.
|
|
Academic Article
|
Real-World Comparative Effectiveness of Tofacitinib and Tumor Necrosis Factor Inhibitors as Monotherapy and Combination Therapy for Treatment of Rheumatoid Arthritis.
|
|
Academic Article
|
Real-World Outcomes Associated With Methotrexate, Sulfasalazine, and Hydroxychloroquine Triple Therapy Versus Tumor Necrosis Factor Inhibitor/Methotrexate Combination Therapy in Patients With Rheumatoid Arthritis.
|
|
Academic Article
|
Weight Fluctuation and the Risk of Cardiovascular Events in Patients With Rheumatoid Arthritis.
|
|
Academic Article
|
Hydroxychloroquine and the risk of respiratory infections among RA patients.
|
|
Academic Article
|
The Clinical Disease Activity Index and the Routine Assessment of Patient Index Data 3 for Achievement of Treatment Strategies.
|
|
Academic Article
|
Short-term dose and duration-dependent glucocorticoid risk for cardiovascular events in glucocorticoid-naive patients with rheumatoid arthritis.
|
|
Academic Article
|
Obesity and Response to Advanced Therapies in Rheumatoid Arthritis.
|
|
Academic Article
|
Reply.
|
|
Academic Article
|
Anti-citrullinated protein antibody profiles predict changes in disease activity in patients with rheumatoid arthritis initiating biologics.
|
|
Academic Article
|
Does the Type of Failure and the Choice of the Second Biologic Influence Response and Persistence on Medication in Rheumatoid Arthritis?
|
|
Academic Article
|
A Model to Predict Future Biologic or Targeted Synthetic DMARD Switch at a Subsequent Clinic Visit in Rheumatoid Arthritis.
|
|
Academic Article
|
Prevalence of Fibromyalgia and Widespread Pain in Psoriatic Arthritis: Association With Disease Severity Assessment in a Large US Registry.
|
|
Academic Article
|
Effect of biologic agents and inflammation on lipid levels and cardiovascular risk in rheumatoid arthritis patients.
|